New research is being presented at HFSA 2014, the 18th Annual Scientific Meeting of the Heart Failure Society of America, from September 14 to 17 in Las Vegas.


Meeting Highlights

Iron & Inflammation in Pulmonary Hypertension

DSE Screening Accurately Predicted post-Transplant Adverse Events

Arrhythmias Common After LVAD Implantation; Did Not increase Mortality Risk

Shared End-of-Life Decisions in Patients With ICDs

Improving Care With Heart Failure Patient Perspectives

Worsening Renal Function in Acute Heart Failure

Left Ventricular End-Diastolic Pressure, STEMI, & PCI


News From HFSA 2014

Withdrawal of HF Meds Can Be Safe After Cardiotoxic Cancer Chemotherapy

Pump Up: Ablation Reverses Poor LV Function in Atrial Fib

MIBG Imaging Aids Risk Assessment for Congestive HF Patients

Elevated CVP After LVAD Implantation Increased GI Bleeding Risk

Trials Bolster Hopes New K-Binding Agents Will Prevent, Treat HF-Related Hyperkalemia

William T. Abraham, MD, Discusses PARACHUTE III Results (Video)

Super Bowl Sunday Shares in the Holiday HF Hazard

As Used, Spironolactone Doesn’t Cut 30-Day HF Readmissions

Poor Sleep, Poor HF Outcomes: Routinely Test Sleep Quality?


More From HFSA 2014


Advance Program


HFSA 2014 Meeting App

CME Information

Clinical Trial Row

Exhibit Hall

Meeting Abstracts

Hyde Park Session

Late-Breaking Clinical Trials

Ground Transportation

Hotel & Lodging Information